BAX · Baxter International Inc
$27.01
-0.32 (-1.17%)
At close · Aug 6
Market Cap
$13.96B
Shares
517.00M
Baxter International Inc Earnings Call Transcripts
Every quarterly earnings call for Baxter International Inc (BAX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲11.9%
$3.61B
−$2.94B
'22 Q3
22-10-27
▲30.2%
$3.75B
$181.00M
'22 Q4
23-02-09
▼31.4%
$2.44B
$44.00M
'23 Q1
23-04-27
▼27.9%
$2.59B
−$141.00M
'23 Q2
23-07-27
▼28%
$2.60B
$2.51B
'23 Q3
23-11-02
▼27.1%
$2.73B
$245.00M
'23 Q4
24-02-08
▲2%
$2.49B
$37.00M
'24 Q1
24-05-02
▲4%
$2.69B
−$314.00M
'24 Q2
24-08-06
▲3.8%
$2.70B
$140.00M
'24 Q3
24-11-08
▲0.9%
$2.75B
−$512.00M
'24 Q4
25-02-03
▲5.4%
$2.62B
$126.00M
'25 Q1
25-05-01
▲4.3%
$2.81B
$91.00M
'25 Q2
25-07-31
▲5%
$2.83B
−$46.00M
'25 Q3
25-10-30
▲8%
$2.97B
−$1.13B
'25 Q4
26-02-12
▲2.9%
$2.70B
−$15.00M
'26 Q1
26-04-30
LATEST
▲5.3%
$2.96B
$126.00M
'26 Q2
26-07-30
Earnings call
FY26 · Q2
2026-07-30
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
Positive tone
Strategic priorities and turnaround
Tariff refund and EPS outlook
Organic revenue growth and Q2 results
Revenue
$2.96B
▲ 5.3% YoY Diluted EPS
$0.24
▲ 33.3% YoY Gross margin
34.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-05-05
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Baxter International Inc Q1 FY2026 Earnings Call
Positive tone
Novum LVP field actions and remediation
Leadership and CFO search
Balance sheet and cash flow / leverage
Revenue
$2.70B
▲ 2.9% YoY Diluted EPS
$-0.03
▼ 112% YoY Gross margin
33.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-11
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-12
Baxter International Inc Q4 FY2025 Earnings Call
Cautious tone
2026 guidance and macro/tariffs
Balance sheet and deleveraging
Operating model restructuring
Revenue
$2.97B*
▲ 8% YoY Gross margin
19.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Baxter International Inc Q3 FY2025 Earnings Call
Cautious tone
CEO transition and stabilization
Fluid conservation and inventory
Balance sheet and dividend cut
Revenue
$2.83B
▲ 5% YoY Diluted EPS
$-0.09
▼ 133.3% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Baxter International Inc Q2 FY2025 Earnings Call
Cautious tone
Operating margin / cost pressure
IV fluid conservation
North Cove / Vizient partnership
Revenue
$2.81B
▲ 4.3% YoY Diluted EPS
$0.18
Gross margin
35.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Baxter International Inc Q1 FY2025 Earnings Call
Positive tone
Kidney Care / Vantive divestiture
2025 financial outlook
Hurricane Helene / North Cove IV recovery
Revenue
$2.62B
▲ 5.4% YoY Diluted EPS
$0.25
▲ 257.1% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Baxter International Inc Q4 FY2024 Earnings Call
Confident tone
2024 results and 2025 outlook
Hospital products and therapies segments
North Cove hurricane recovery
Revenue
$2.75B
▲ 0.9% YoY Diluted EPS
$-1.00
▼ 308.3% YoY Gross margin
34.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Baxter International Inc Q3 FY2024 Earnings Call
Positive tone
Kidney Care Divestiture
2025 Financial Outlook
North Cove Hurricane Recovery
Revenue
$2.70B
▲ 3.8% YoY Diluted EPS
$0.27
▼ 94.5% YoY Gross margin
38.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Baxter International Inc Q2 FY2024 Earnings Call
Positive tone
Strategic transformation and Kidney Care separation
2025 outlook and exit rate
Front Line Care / primary care softness
Revenue
$2.69B
▲ 4% YoY Diluted EPS
$-0.61
Gross margin
38.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Baxter International Inc Q1 FY2024 Earnings Call
Positive tone
Geographic expansion of Hillrom / HST internationally
Margin improvement and supply chain execution
Healthcare Systems & Technologies (HST) underperformance
Revenue
$2.49B
▲ 2% YoY Diluted EPS
$0.07
▼ 22.2% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Baxter International Inc Q4 FY2023 Earnings Call
Positive tone
Pricing and GPO contracts
Kidney Care / Vantive separation
Segment performance (Medical Products, HST, Pharmaceuticals)
Revenue
$2.73B
▼ 27.1% YoY Diluted EPS
$0.48
▲ 33.3% YoY Gross margin
40.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Baxter International Inc Q3 FY2023 Earnings Call
Revenue
$2.60B
▼ 28% YoY Diluted EPS
$4.93
Gross margin
40.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Baxter International Inc Q2 FY2023 Earnings Call
Revenue
$2.59B
▼ 27.9% YoY Diluted EPS
$-0.28
▼ 156% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Baxter International Inc Q1 FY2023 Earnings Call
Revenue
$2.44B
▼ 31.4% YoY Diluted EPS
$0.09
▼ 35.7% YoY Gross margin
39.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Baxter International Inc Q4 FY2022 Earnings Call
Revenue
$3.75B
▲ 30.2% YoY Diluted EPS
$0.36
Gross margin
37.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Baxter International Inc Q3 FY2022 Earnings Call
Revenue
$3.61B
▲ 11.9% YoY Diluted EPS
$-5.83
▼ 755.1% YoY Gross margin
29.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Baxter International Inc Q2 FY2022 Earnings Call
Revenue
$3.59B
▲ 16% YoY Diluted EPS
$0.50
▼ 15.3% YoY Gross margin
38.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Baxter International Inc Q1 FY2022 Earnings Call
Revenue
$3.56B
▲ 20.8% YoY Diluted EPS
$0.14
▼ 75.9% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Baxter International Inc Q4 FY2021 Earnings Call
Revenue
$2.88B*
▼ 9.6% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Baxter International Inc Q3 FY2021 Earnings Call
Revenue
$3.23B
▲ 8.5% YoY Diluted EPS
$0.89
▲ 29% YoY Gross margin
40.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Baxter International Inc Q2 FY2021 Earnings Call
Revenue
$3.10B
▲ 14% YoY Diluted EPS
$0.59
▲ 22.9% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Baxter International Inc Q1 FY2021 Earnings Call
Revenue
$2.95B
▲ 5.1% YoY Diluted EPS
$0.58
▼ 9.4% YoY Gross margin
38.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Baxter International Inc Q4 FY2020 Earnings Call
Revenue
$3.18B
▲ 4.7% YoY Diluted EPS
$0.33
Gross margin
37.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Baxter International Inc Q3 FY2020 Earnings Call
Revenue
$2.97B
▲ 4.2% YoY Diluted EPS
$0.69
▼ 2.8% YoY Gross margin
40.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Baxter International Inc Q2 FY2020 Earnings Call
Revenue
$2.72B
▼ 4.1% YoY Diluted EPS
$0.48
▼ 20% YoY Gross margin
38.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Baxter International Inc Q1 FY2020 Earnings Call
Revenue
$2.80B
▲ 6.2% YoY Diluted EPS
$0.64
▼ 3% YoY Gross margin
41.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-17
Baxter International Inc Q4 FY2019 Earnings Call
Revenue
$3.04B
▲ 7.3% YoY Diluted EPS
$-0.05
▼ 108.8% YoY Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls
Key facts
CIK
10456
CUSIP
071813109
13F (30d)
354 filings
328 filers
Visit website
Investor relations